Clinical Trial Update: Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC [Phase 1]

View source ↗

Summary

Pfizer's Phase 1 trial of a vaccine-based immunotherapy regimen for non-small cell lung cancer and triple-negative breast cancer was terminated, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Pfizer vaccine-based immunotherapy regimen

Snippet

Sponsor: Pfizer | Conditions: Non-Small Cell Lung Cancer, Triple-negative Breast Cancer | Phase 1 | Status: TERMINATED | Results posted: 2024-08-23